Fermenta Biotech Ltd Stock Price Today (NSE: FERMENTA)
Fundamental Score
Fermenta Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fermenta Biotech Ltd share price today is ₹313.40, up +4.34% on NSE/BSE as of 19 June 2026. Fermenta Biotech Ltd (FERMENTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹818.18 (Cr). The 52-week high for FERMENTA share price is ₹399.00 and the 52-week low is ₹256.40. At a P/E ratio of 7.30x, FERMENTA is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 24.88% and a debt-to-equity ratio of 0.29.
Fermenta Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Fermenta Biotech Ltd share price chart: -6.70% return over the past month. 52-week high ₹399.00, 52-week low ₹256.40.
Fermenta Biotech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹303.00 | ₹318.00 | ₹303.00 | ₹313.40 | 15.24K (Cr) | |
| ₹302.75 | ₹307.10 | ₹296.85 | ₹300.35 | 7.10K (Cr) | |
| ₹298.45 | ₹300.05 | ₹292.05 | ₹295.20 | 2.53K (Cr) | |
| ₹287.55 | ₹296.35 | ₹287.50 | ₹293.20 | 4.39K (Cr) | |
| ₹306.15 | ₹309.00 | ₹289.95 | ₹290.60 | 13.47K (Cr) | |
| ₹310.00 | ₹310.00 | ₹297.20 | ₹302.00 | 3.83K (Cr) | |
| ₹308.90 | ₹308.90 | ₹301.50 | ₹302.65 | 1.63K (Cr) | |
| ₹307.00 | ₹310.95 | ₹302.10 | ₹303.60 | 3.78K (Cr) | |
| ₹301.90 | ₹310.00 | ₹288.55 | ₹307.95 | 6.87K (Cr) | |
| ₹288.65 | ₹297.00 | ₹287.35 | ₹293.95 | 1.92K (Cr) |
Fermenta Biotech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹302.75 | ₹318.00 | ₹296.85 | ₹313.40 | +3.52% | |
| ₹309.50 | ₹318.05 | ₹278.40 | ₹295.20 | -4.62% | |
| ₹330.00 | ₹348.90 | ₹308.00 | ₹311.40 | -5.64% | |
| ₹320.10 | ₹362.00 | ₹306.30 | ₹319.05 | -0.33% | |
| ₹328.90 | ₹344.00 | ₹294.80 | ₹325.35 | -1.08% | |
| ₹351.00 | ₹354.50 | ₹305.00 | ₹322.30 | -8.18% | |
| ₹285.00 | ₹360.00 | ₹256.40 | ₹348.00 | +22.11% | |
| ₹279.40 | ₹299.00 | ₹265.00 | ₹282.65 | +1.16% | |
| ₹319.95 | ₹330.00 | ₹256.50 | ₹275.65 | -13.85% | |
| ₹319.90 | ₹376.00 | ₹297.00 | ₹311.95 | -2.49% | |
| ₹369.00 | ₹369.00 | ₹315.15 | ₹317.55 | -13.94% | |
| ₹333.90 | ₹399.00 | ₹315.75 | ₹369.35 | +10.62% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Fermenta Biotech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fermenta Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FERMENTA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (24.88%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.97%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (15.97%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 7.30 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (65.91%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (37.03%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.15x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹213.64 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (64.09%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 0.02%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Fermenta Biotech Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Fermenta Biotech Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Fermenta Biotech LtdFermenta Biotec...Selected✓ FERMENTA • 506414 | 67.5/100 | ₹313.40₹313 | ₹818.18₹818.18 | 7.30Average 7.3 Average | 24.88%Excellent 24.88% Excellent | 22.97%Excellent 22.97% Excellent | 0.29Excellent 0.3 Excellent | 7.00%Good 7.00% Good | 9.89%Good 9.89% Good | 0.90% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Fermenta Biotech Ltd PE Ratio History
Historical price-to-earnings ratio for FERMENTA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹26.35 | ₹348.00 | 13.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Fermenta Biotech Ltd Dividend History
Annual cash dividends paid by FERMENTA — dividend yield 0.90%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.61 Cr |
| FY 2024 | ₹3.61 Cr |
| FY 2023 | ₹4.20 Cr |
| FY 2022 | ₹7.21 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Fermenta Biotech Ltd Quarterly Performance
Latest quarterly metrics for FERMENTA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
37.03%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
65.91%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.89%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
7.00%
Compounded annual net profit growth over 5 years
Fermenta Biotech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for FERMENTA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Fermenta Biotech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Fermenta Biotech Ltd (FERMENTA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Fermenta Biotech Ltd
About FERMENTA (Fermenta Biotech Ltd)
Fermenta Biotech Ltd is a dynamic pharmaceutical company carving a niche for itself in the global landscape. Beyond its core function of manufacturing, Fermenta Biotech actively cu...ltivates innovative solutions for a healthier future. It's not just about churning out drugs, but about strategically developing and marketing a diverse portfolio of chemical compounds, high-quality bulk drug substances, and specialized enzymes, all meticulously crafted to meet stringent international standards. This dedication extends beyond human health, encompassing environmental solutions designed to promote sustainability and responsible practices within the industry. With a commitment to research and development, Fermenta is continuously exploring new frontiers in biotechnology, aiming to deliver impactful products that improve quality of life. Fermenta Biotech’s influence expands beyond the laboratory, reaching into the realms of health and wellness through education and community engagement. Recognizing the importance of preventative care, the company actively supports initiatives aimed at raising health awareness and promoting healthy lifestyles. This holistic approach reflects a dedication to improving the well-being of individuals and communities. Furthermore, Fermenta Biotech showcases a smart business acumen by strategically managing property assets, indicating a financially sound approach to long-term sustainability and growth. This blend of scientific innovation, responsible environmental practices, and shrewd business decisions positions Fermenta as a forward-thinking player in the pharmaceutical sector. Central to Fermenta Biotech's product offerings is a diverse range of Vitamin D3 variants, carefully formulated to address the specific needs of various industries. From crystalline oil for pharmaceutical applications to feed-grade powder for animal nutrition, the company leverages its expertise in biotechnology to deliver tailored solutions. These products are rigorously tested and manufactured under strict quality control measures, ensuring efficacy and safety for consumers. The company's continuous investment in research and development reflects its commitment to staying at the forefront of innovation and providing high-quality products that contribute to improved health outcomes and nutritional well-being across diverse sectors.
Company Details
Key Leadership
Corporate Events
Latest News
FERMENTA Share Price: Frequently Asked Questions
What is the current share price of Fermenta Biotech Ltd?
Fermenta Biotech Ltd (FERMENTA) trades at ₹313.40 on NSE and BSE. Market cap ₹818.18 (Cr). Educational data only.
What is the P/E ratio of Fermenta Biotech Ltd?
Fermenta Biotech Ltd has a P/E of 7.30x vs industry average 31.77x.
What is the Bull Run score for Fermenta Biotech Ltd?
Fermenta Biotech Ltd has a Bull Run score of 67.5/100 based on 25+ financial parameters.
Does Fermenta Biotech Ltd pay dividends?
Fermenta Biotech Ltd has a dividend yield of 0.90%. Past dividends don't guarantee future payments.
What is the ROE of Fermenta Biotech Ltd?
Fermenta Biotech Ltd has ROE of 24.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Fermenta Biotech Ltd?
Fermenta Biotech Ltd has debt-to-equity of 0.29.
Is Fermenta Biotech Ltd a good investment?
Bull Run gives Fermenta Biotech Ltd a score of 67.5/100. This is not investment advice — consult a SEBI-registered advisor.